The Kaihani Score is a blood based means of assessing molecules believed to be associated with gambling addiction. The current clinical trial will assess the Kaihani Score in 3 groups: Group 1: 10 patients with no personal or family problems with gambling as assessed by the PG-YBOCS (obsessions-compulsions scale Yale-Brown (Y-BOCS), adapted for pathological gambling) (PG-YBOCS). Group 2: 10 patients with moderate gambling addiction as assessed by the PG-YBOCS (obsessions-compulsions scale Yale-Brown (Y-BOCS), adapted for pathological gambling) (PG-YBOCS). Group 3: 10 patients with severe gambling addiction as assessed by the PG-YBOCS (obsessions-compulsions scale Yale-Brown (Y-BOCS), adapted for pathological gambling) (PG-YBOCS). The goal of the study is to confirm preliminary efficacy of the Kaihani Score as a blood based means of assessing gambling propensity.
Study Type
OBSERVATIONAL
Enrollment
30
Assessment of neuromodulatory chemicals in peripheral blood plasma samples.
Therapeutic Solutions International
Oceanside, California, United States
RECRUITINGAssessment of Kaihani Score
Kaihani Score will be compared between non-gamblers, moderate gamblers, and severe gamblers.
Time frame: 1 Week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.